MPM Capital
Investor Login
  • Home
  • About
  • Companies
  • Team
  • Contact
  • Press
Back to press

September 1, 2017

Gormley’s Take: Writing War on Cancer’s Next Chapter –– Biotech startups seek to widen benefits of revolutionary cell-therapy treatments

WSJ Pro Venture Capital features MPM’s Chris Bardon and TCR2

  • Read full article
  • Copyright © 2022 MPM Capital, Inc.

    X
    X
    X

    Please click here for all funds: Investor Login

    X